Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Revolution Medicines in the United States is seeking a Director, Revenue Accounting and Finance to lead revenue recognition, gross-to-net, close processes, and forecasting as the company scales its commercial operations.
The role partners with Commercial, Market Access and Analytics to translate market dynamics into financial insight, establishing scalable controls and advanced analytics to support growth.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients.
The Opportunity:
Revolution Medicines is seeking a Director, Revenue Accounting and Finance to provide leadership across revenue accounting, gross to net accounting and forecasting, and related commercial finance activities as the company continues to scale its commercial operations.
Reporting to the Senior Director, Revenue Accounting and Finance, this role will lead critical revenue and gross to net processes, including financial close, forecasting, controls, government pricing coordination, analytics, and global revenue reporting. The Director will balance strong operational execution with longer term process development, helping establish scalable methodologies, controls, and reporting capabilities to support the company's continued commercial growth.
This individual will serve as a senior Finance partner to Commercial, Market Access, Analytics & Insights, Corporate Accounting, FP&A, and regional Finance teams. The ideal candidate will bring deep pharmaceutical revenue and gross to net expertise, strong technical accounting judgment, and the ability to lead complex cross functional initiatives, influence business decisions, and translate commercial and market dynamics into actionable financial insights.